David Watkins - The Royal Marsden

More documents

Recommendations

Info

The Royal Marsden Hodgkin lymphoma ABVD Adriamycin (doxorubicin) Bleomycin Vinblastine Dacarbazine Given by IV injection on day 1 and day 15 Repeated every 28 days
The Royal Marsden Hodgkin lymphoma ABVD Adriamycin (doxorubicin) Bleomycin Vinblastine Dacarbazine Given by IV injection on day 1 and day 15 Repeated every 28 days Developed in the 1970’s and remains the standard of care Response usually rapid. CT imaging undertaking every 2 cycles Stage I/IIA Typical treatment would consists of 2 - 4 cycles of ABVD followed by radiotherapy to sites of disease involvement Survival rates of 90-95% Stage IIB-IV Typical treatment would consists of 6-8 cycles of ABVD and possible radiotherapy to bulky sites ~30% will suffer disease relapse with 5 years survival rates of 80-90%
Page 1 and 2: The Royal Marsden Principles of che
Page 3 and 4: The Royal Marsden What has resulted
Page 5 and 6: The Royal Marsden Defining treatmen
Page 7 and 8: The Royal Marsden
Page 9 and 10: The Royal Marsden Lymphoma classifi
Page 11 and 12: The Royal Marsden Chemotherapy nami
Page 13 and 14: The Royal Marsden Curative strategy
Page 15 and 16: The Royal Marsden Balancing Risks v
Page 17 and 18: The Royal Marsden What is the most
Page 19: The Royal Marsden Hodgkin lymphoma
Page 23 and 24: The Royal Marsden ABVD specific tox
Page 25 and 26: The Royal Marsden Other Hodgkin lym
Page 27 and 28: The Royal Marsden Novel approaches
Page 29 and 30: The Royal Marsden R-CHOP High grade
Page 31 and 32: The Royal Marsden How confident are
Page 33 and 34: The Royal Marsden Developments in D
Page 35 and 36: The Royal Marsden Management of rel
Page 37 and 38: The Royal Marsden Treating follicul
Page 39 and 40: The Royal Marsden Rituximab Which o

David Watkins - The Royal Marsden

Create successful ePaper yourself

Delete template?

Save as template?